Functional Characterization of PPAR^-Dependent Gene Networks in Macrophages.
Functional Characterization of PPAR^-Dependent Gene Networks in Macrophages.
批准号:
8355985
负责人:
Christopher K Glass
金额:
$41.77万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
未结题
起止时间:
2007-05-01 至
关键词:
2,4-thiazolidinedione3-DimensionalActinsAdipocytesAdipose tissueAnimalsAnti-Inflammatory AgentsAnti-inflammatoryCell NucleusChromatinCollaborationsComplementComplexDevelopmentDietEnvironmentEvaluationExhibitsFatty AcidsFatty acid glycerol estersFutureGene ExpressionGene TargetingGenesInflammatoryInflammatory ResponseInsulinInsulin ResistanceInterferonsInterleukin-4InvestigationLigandsLocationMacrophage ActivationMaintenanceMediatingMethodsMolecularMovementNon-Insulin-Dependent Diabetes MellitusNuclearNuclear ReceptorsObesityPathway interactionsPeroxisome Proliferator-Activated ReceptorsPhenotypePhysiologicalPlayPolyunsaturated Fatty AcidsProductionRNARegulationRepressionRoleShapesSignal PathwaySignal TransductionTLR4 geneTestingTherapeuticTherapeutic EffectTherapeutic InterventionThiazolidinedionesTissuesToll-like receptorsTranscriptbaseblood glucose regulationcytokinediabeticgenome wide association studygenome-wideimprovedin vivoinnovationinsulin sensitivitylong chain fatty acidmacrophagenovel strategiespalmitoleic acidpreventreceptorresponse
中文摘要
项目3将研究巨噬细胞中影响胰岛素抵抗的转录网络。我们提出的研究将主要集中在理解巨噬细胞中NCoR辅阻遏物缺失的意外生理和细胞后果,以及定义巨噬细胞PPARy有助于正常葡萄糖稳态和胰岛素增敏作用的分子机制。
噻唑烷二酮类(TZDs)。这些研究将补充项目1和2中的研究,以提高我们对推动胰岛素抵抗发展的中枢致病机制的理解。特异性目的1将检验以下假设:由于驱动抗炎脂肪酸产生的LXR和/或PPARy靶基因的去阻遏,NCor的巨噬细胞特异性破坏导致胰岛素敏感性增强。这些研究有可能确定一个全新的途径,巨噬细胞影响胰岛素抵抗,可能是可行的治疗干预。具体目标2将研究巨噬细胞PPARy有助于正常葡萄糖稳态的机制
和TZD的抗糖尿病作用。我们将检验这样的假设,即PPARy的全基因组位置和功能在肥胖脂肪组织的脂肪组织巨噬细胞中受到损害,并通过胰岛素增敏PPARy配体恢复。这些研究将利用新的体内方法来确定巨噬细胞特异性过氧化物酶体增殖体激活受体在脂肪组织中的位置和功能,而不需要广泛的纯化
方法.将与项目2合作开展特定目标3的研究,以检验替代性巨噬细胞活化改变染色质相互作用组以促进PPAR γ依赖性基因表达并拮抗TLR 4依赖性基因表达的假设。这些研究将测试一个新的概念
以了解抗炎和促炎信号是如何在细胞核的三维水平上整合的。
英文摘要
Project 3 will investigate transcriptional networks in macrophages that influence Insulin resistance. Our proposed studies will primarily focus on understanding unexpected physiological and cellular consequences of deletion of the NCoR co-repressor in macrophages and on deflning the molecular mechanisms by which macrophage PPARy contributes to normal glucose homeostasis and insulin sensitizing effects of
thiazolidinediones (TZDs). These lines of investigation will complement studies performed in Projects 1 and 2 to improve our understanding of central pathogenic mechanisms that drive the development of insulin resistance. Speciflc Aim 1 will test the hypothesis that macrophage-speciflc disruption of NCor results in enhanced insulin sensitivity due to de-repression of LXR and/or PPARy target genes that drive production of anti-inflammatory fatty acids. These studies have the potential to identify a fundamentally new pathway by which macrophages influence insulin resistance that may be amendable to therapeutic intervention. Specific Aim 2 will investigate mechanisms by which macrophage PPARy contributes to normal glucose homeostasis
and anti-diabetic effects of TZDs. We will test the hyothesis that the genome-wide locations and functions of PPARy are compromised in adipose tissue macrophages of obese adipose tissue and are restored by insulin-sensitizing PPARy ligands. These studies will make use of new in vivo approaches for determining macrophage-specific PPAR location and function in adipose tissue that do not require extensive purification
methods. Studies in Specific Aim 3 will be performed in collaboration with Project 2 to test the hypothesis that alternative macrophage activation alters the chromatin interactome so as to facilitate PPARy-dependent gene expression and antagonize TLR4-dependent gene expression. These studies will test a new concept
for understanding how anti-inflammatory and pro-inflammatory signals are integrated at a 3 dimensional level in the nucleus.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?
-
批准号:10683961
-
项目类别:
-
资助金额:$249.25万
-
财政年份:2020
-
负责人:Christopher K Glass
-
依托单位:
Macrophage-specific targeting of LXRs in CVD and NASH
-
批准号:10262918
-
项目类别:
-
资助金额:$36.84万
-
财政年份:2020
-
负责人:Christopher K Glass
-
依托单位:
A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?
-
批准号:10262913
-
项目类别:
-
资助金额:$252.51万
-
财政年份:2020
-
负责人:Christopher K Glass
-
依托单位:
Macrophage-specific targeting of LXRs in CVD and NASH
-
批准号:10461064
-
项目类别:
-
资助金额:$36.81万
-
财政年份:2020
-
负责人:Christopher K Glass
-
依托单位:
A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?
-
批准号:10461059
-
项目类别:
-
资助金额:$251.82万
-
财政年份:2020
-
负责人:Christopher K Glass
-
依托单位:
Administrative Core
-
批准号:10683963
-
项目类别:
-
资助金额:$12.54万
-
财政年份:2020
-
负责人:Christopher K Glass
-
依托单位:
Macrophage-specific targeting of LXRs in CVD and NASH
-
批准号:10683973
-
项目类别:
-
资助金额:$36.84万
-
财政年份:2020
-
负责人:Christopher K Glass
-
依托单位:
Administrative Core
-
批准号:10262915
-
项目类别:
-
资助金额:$12.54万
-
财政年份:2020
-
负责人:Christopher K Glass
-
依托单位:
Administrative Core
-
批准号:10461061
-
项目类别:
-
资助金额:$12.53万
-
财政年份:2020
-
负责人:Christopher K Glass
-
依托单位:
The Enhancer Code of AD-A Genetic Approach
-
批准号:9905343
-
项目类别:
-
资助金额:$106.13万
-
财政年份:2018
-
负责人:Christopher K Glass
-
依托单位:
The Enhancer Code of AD-A Genetic Approach
-
批准号:9752405
-
项目类别:
-
资助金额:$106.08万
-
财政年份:2018
-
负责人:Christopher K Glass
-
依托单位:
The Enhancer Code of AD-A Genetic Approach
-
批准号:10399455
-
项目类别:
-
资助金额:$106.37万
-
财政年份:2018
-
负责人:Christopher K Glass
-
依托单位:
Mechanisms controlling human microglia gene expression
-
批准号:9081167
-
项目类别:
-
资助金额:$38.27万
-
财政年份:2016
-
负责人:Christopher K Glass
-
依托单位:
Mechanisms controlling human microglia gene expression
-
批准号:9271257
-
项目类别:
-
资助金额:$38.27万
-
财政年份:2016
-
负责人:Christopher K Glass
-
依托单位:
Mechanisms controlling human microglia gene expression
-
批准号:10495183
-
项目类别:
-
资助金额:$47.16万
-
财政年份:2016
-
负责人:Christopher K Glass
-
依托单位:
Enhancer Therapy
-
批准号:8411811
-
项目类别:
-
资助金额:$129.32万
-
财政年份:2012
-
负责人:Christopher K Glass
-
依托单位:
Enhancer Therapy
-
批准号:8921152
-
项目类别:
-
资助金额:$127.13万
-
财政年份:2012
-
负责人:Christopher K Glass
-
依托单位:
Enhancer Therapy
-
批准号:8712212
-
项目类别:
-
资助金额:$127.46万
-
财政年份:2012
-
负责人:Christopher K Glass
-
依托单位:
PROJECT 1: SPATIOTEMPORAL GENOME ARCHITECTURE
-
批准号:8957391
-
项目类别:
-
资助金额:$51.07万
-
财政年份:2010
-
负责人:Christopher K Glass
-
依托单位:
PROJECT 1: SPATIOTEMPORAL GENOME ARCHITECTURE
-
批准号:9293325
-
项目类别:
-
资助金额:$28.72万
-
财政年份:2010
-
负责人:Christopher K Glass
-
依托单位:
海外基金